Related references
Note: Only part of the references are listed.Rotigotine Effects on Early Morning Motor Function and Sleep in Parkinson's Disease: A Double-Blind, Randomized, Placebo-Controlled Study (RECOVER)
Claudia Trenkwalder et al.
MOVEMENT DISORDERS (2011)
Twice-Daily, Low-Dose Pramipexole in Early Parkinson's Disease: A Randomized, Placebo-Controlled Trial
Karl Kieburtz
MOVEMENT DISORDERS (2011)
Anti-depressive treatment in Parkinson's disease A CONTROLLED TRIAL OF THE EFFECT OF NORTRIPTYLINE IN PATIENTS WITH PARKINSON'S DISEASE TREATED WITH L-DOPA
J. Andersen et al.
ACTA NEUROLOGICA SCANDINAVICA (2010)
KR 339 IN THE TREATMENT OF PARKINSONIAN TREMOR
Matti Iivanainen
ACTA NEUROLOGICA SCANDINAVICA (2010)
THE EFFECT OF ADDING AMANTADINE TO OPTIMUM L-DOPA DOSAGE IN PARKINSON'S SYNDROME
Clas Fehling
ACTA NEUROLOGICA SCANDINAVICA (2010)
Effects of bromocriptine on Parkinsonism A nation-wide collaborative double-blind study
Yasuo Toyokura et al.
ACTA NEUROLOGICA SCANDINAVICA (2010)
Nocturnal subcutaneous apomorphine infusion in Parkinson's disease and restless legs syndrome
I. Reuter et al.
ACTA NEUROLOGICA SCANDINAVICA (2010)
Selegiline in Parkinson's disease
H. Teräväinen
ACTA NEUROLOGICA SCANDINAVICA (2010)
Downhill Walking Training in Individuals with Parkinson's Disease A Randomized Controlled Trial
Yea-Ru Yang et al.
AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION (2010)
Initiating Levodopa/Carbidopa Therapy With and Without Entacapone in Early Parkinson Disease The STRIDE-PD Study
Fabrizio Stocchi et al.
ANNALS OF NEUROLOGY (2010)
Decision-making in Parkinson's disease patients with and without pathological gambling
M. Rossi et al.
EUROPEAN JOURNAL OF NEUROLOGY (2010)
Pramipexole for the treatment of depressive symptoms in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled trial
Paolo Barone et al.
LANCET NEUROLOGY (2010)
Memantine for patients with Parkinson's disease dementia or dementia with Lewy bodies: a randomised, double-blind, placebo-controlled trial
Murat Emre et al.
LANCET NEUROLOGY (2010)
Self-management Rehabilitation and Health-Related Quality of Life in Parkinson's Disease: A Randomized Controlled Trial
Linda Tickle-Degnen et al.
MOVEMENT DISORDERS (2010)
Efficacy, Safety, and Tolerability of Overnight Switching from Immediate- to Once Daily Extended-Release Pramipexole in Early Parkinson's Disease
Olivier Rascol et al.
MOVEMENT DISORDERS (2010)
Long-Term Antidyskinetic Efficacy of Amantadine in Parkinson's Disease
Elisabeth Wolf et al.
MOVEMENT DISORDERS (2010)
Randomized, Double-Blind, Multicenter Evaluation of Pramipexole Extended Release Once Daily in Early Parkinson's Disease
Robert A. Hauser et al.
MOVEMENT DISORDERS (2010)
Onset of Dyskinesia with Adjunct Ropinirole Prolonged-Release or Additional Levodopa in Early Parkinson's Disease
Ray L. Watts et al.
MOVEMENT DISORDERS (2010)
The Effects of an Exercise Program on Fall Risk Factors in People with Parkinson's Disease: A Randomized Controlled Trial
Natalie E. Allen et al.
MOVEMENT DISORDERS (2010)
Comparing Exercise in Parkinson's Disease-The Berlin LSVT®BIG Study
Georg Ebersbach et al.
MOVEMENT DISORDERS (2010)
Atomoxetine for depression and other neuropsychiatric symptoms in Parkinson disease
D. Weintraub et al.
NEUROLOGY (2010)
Pallidal versus Subthalamic Deep-Brain Stimulation for Parkinson's Disease
Kenneth A. Follett et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
The effect of psychotherapy in patients with PD: A controlled study
Erika Sproesser et al.
PARKINSONISM & RELATED DISORDERS (2010)
Behavioural Adverse Effects of Dopaminergic Treatments in Parkinson's Disease Incidence, Neurobiological Basis, Management and Prevention
Angelo Antonini et al.
DRUG SAFETY (2009)
Rotigotine transdermal delivery for the treatment of Parkinson's disease
Olivier Rascol et al.
EXPERT OPINION ON PHARMACOTHERAPY (2009)
Bilateral Deep Brain Stimulation vs Best Medical Therapy for Patients With Advanced Parkinson Disease A Randomized Controlled Trial
Frances M. Weaver et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Treadmill training for the treatment of gait disturbances in people with Parkinson's disease: a mini-review
T. Herman et al.
JOURNAL OF NEURAL TRANSMISSION (2009)
Botulinum Toxin A for Overactive Bladder and Detrusor Muscle Overactivity in Patients With Parkinson's Disease and Multiple System Atrophy
Antonella Giannantoni et al.
JOURNAL OF UROLOGY (2009)
Memantine in patients with Parkinson's disease dementia or dementia with Lewy bodies: a double-blind, placebo-controlled, multicentre trial
Dag Aarsland et al.
LANCET NEUROLOGY (2009)
Randomized Controlled Trial of Memantine in Dementia Associated with Parkinson's Disease
Iracema Leroi et al.
MOVEMENT DISORDERS (2009)
Patient Profile, Indications, Efficacy and Safety of Duodenal Levodopa Infusion in Advanced Parkinson's Disease
David Devos
MOVEMENT DISORDERS (2009)
Quality of Life in Early Parkinson's Disease Treated with Levodopa/Carbidopa/Entacapone
Victor S. C. Fung et al.
MOVEMENT DISORDERS (2009)
Double-Blind Trial of Levodopa/Carbidopa/Entacapone Versus Levodopa/Carbidopa in Early Parkinson's Disease
Robert A. Hauser et al.
MOVEMENT DISORDERS (2009)
Rehabilitation Treatment of Gait in Patients with Parkinson's Disease with Freezing: A Comparison Between Two Physical Therapy Protocols Using Visual and Auditory Cues with or Without Treadmill Training
Giuseppe Frazzitta et al.
MOVEMENT DISORDERS (2009)
Symptom and Gait Changes After Sensory Attention Focused Exercise vs Aerobic Training in Parkinson's Disease
Michael D. Sage et al.
MOVEMENT DISORDERS (2009)
A Randomized Controlled Trial of Movement Strategies Compared with Exercise for People with Parkinson's Disease
Meg E. Morris et al.
MOVEMENT DISORDERS (2009)
A controlled trial of antidepressants in patients with Parkinson disease and depression
M. Menza et al.
NEUROLOGY (2009)
A Double-Blind, Delayed-Start Trial of Rasagiline in Parkinson's Disease
C. Warren Olanow et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
The Effects of Exercise on Balance in Persons with Parkinson's Disease: A Systematic Review Across the Disability Spectrum
Leland E. Dibble et al.
JOURNAL OF NEUROLOGIC PHYSICAL THERAPY (2009)
A multicentre study on suicide outcomes following subthalamic stimulation for Parkinsons disease
Valerie Voon et al.
BRAIN (2008)
Does treadmill training improve lower-extremity tasks in Parkinson disease? A randomized controlled trial
Yesim Kurtais et al.
CLINICAL JOURNAL OF SPORT MEDICINE (2008)
Ropinirole 24-hour prolonged release and ropinirole immediate release in early Parkinson's disease: a randomized, double-blind, non-inferiority crossover study
Fabrizio Stocchi et al.
CURRENT MEDICAL RESEARCH AND OPINION (2008)
Tai Chi improves balance and mobility in people with Parkinson disease
Madeleine E. Hackney et al.
GAIT & POSTURE (2008)
Five-year efficacy and safety of levodopa/DDCI and entacapone in patients with Parkinson's disease
David J. Brooks et al.
JOURNAL OF NEURAL TRANSMISSION (2008)
Neuropsychological and psychiatric changes after deep brain stimulation for Parkinson's disease:: a randomised, multicentre study
Karsten Witt et al.
LANCET NEUROLOGY (2008)
Cued task-specific training is better than exercise in improving sit-to-stand in patients with Parkinson's disease: A randomized controlled trial
Margaret K. Y. Mak et al.
MOVEMENT DISORDERS (2008)
Comparison of desipramine and citalopram treatments for depression in Parkinson's disease:: A double-blind, randomized, placebo-controlled study
David Devos et al.
MOVEMENT DISORDERS (2008)
Efficacy of long-term continuous subcutaneous apomorphine infusion in advanced Parkinson's disease with motor fluctuations: A multicenter study
Pedro J. Garcia Ruiz et al.
MOVEMENT DISORDERS (2008)
A randomized study of three interventions for aspiration of thin liquids in patients with dementia or Parkinson's disease
Jeri A. Logemanin et al.
JOURNAL OF SPEECH LANGUAGE AND HEARING RESEARCH (2008)
Subthalamic nucleus deep brain stimulation improves deglutition in Parkinson's disease
Michelle R. Ciucci et al.
MOVEMENT DISORDERS (2008)
A pilot study of respiration and swallowing integration in Parkinson's disease: On and Off levodopa
Anthony Lim et al.
DYSPHAGIA (2008)
Effects of bolus consistency on timing and safety of swallow in patients with Parkinson's disease
Michelle S. Troche et al.
DYSPHAGIA (2008)
Ten-year follow-up of Parkinson's disease patients randomized to initial therapy with ropinirole or levodopa
Robert A. Hauser et al.
MOVEMENT DISORDERS (2007)
Rotigotine transdermal patch in early Parkinson's disease: A randomized, double-blind, controlled study versus placebo and ropinirole
Nir Giladi et al.
MOVEMENT DISORDERS (2007)
Ropinirole is effective on motor function when used as an adjunct to levodopa in Parkinson's disease: Strong study
Yoshikuni Mizuno et al.
MOVEMENT DISORDERS (2007)
Nonpharmacological treatment, fludrocortisone, and domperidone for orthostatic hypotension in Parkinson's disease
Kerrie L. Schoffer et al.
MOVEMENT DISORDERS (2007)
The effects of incremental speed-dependent treadmill training on postural instability and fear of failing in Parkinson's disease
Burcu Duyur Cakit et al.
CLINICAL REHABILITATION (2007)
Thirty days complication rate following surgery performed for deep-brain-stimulation
Juergen Voges et al.
MOVEMENT DISORDERS (2007)
Macrogol for the treatment of constipation in Parkinson's disease. A randomized placebo-controlled study
Roberta Zangaglia et al.
MOVEMENT DISORDERS (2007)
A randomised controlled trial of a home based exercise programme to reduce the risk of falling among people with Parkinson's disease
Ann Ashburn et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2007)
Duodenal levodopa infusion for advanced Parkinson's disease: 12-month treatment outcome
Angelo Antonini et al.
MOVEMENT DISORDERS (2007)
Efficacy of pramipexole and transdermal rotigotine in advanced Parkinson's disease: a double-blind, double-dummy, randomised controlled trial
Werner H. Poewe et al.
LANCET NEUROLOGY (2007)
Transdermal rotigotine - Double-blind, placebo-controlled trial in Parkinson disease
Joseph Jankovic et al.
ARCHIVES OF NEUROLOGY (2007)
Improvement of gait by chronic, high doses of methylphenidate in patients with advanced Parkinson's disease
D. Devos et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2007)
Advanced Parkinson disease treated with rotigotine transdermal system - PREFER Study
Peter A. LeWitt et al.
NEUROLOGY (2007)
Ropinirole 24-hour prolonged release - Randomized, controlled study in advanced Parkinson disease
R. Pahwa et al.
NEUROLOGY (2007)
Effect of quetiapine a double-blind in psychotic Parkinson's disease patients: Labeled study of 3 months' duration
Jose M. Rabey et al.
MOVEMENT DISORDERS (2007)
Cueing training in the home improves gait-related mobility in Parkinson's disease: the RESCUE trial
A. Nieuwboer et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2007)
Neurosurgery at an earlier stage of Parkinson disease:: A randomized, controlled trial
W. M. M. Schupbach et al.
NEUROLOGY (2007)
Effect of exogenous melatonin on sleep and motor dysfunction in Parkinson's disease - A randomized, double blind, placebo-controlled study
Camila Andrade Mendes Medeiros et al.
JOURNAL OF NEUROLOGY (2007)
Entacapone to tolcapone switch: Multicenter double-blind, randomized, active-controlled trial in advanced Parkinson's disease
Esko Kinnunen et al.
MOVEMENT DISORDERS (2007)
Clinical efficacy of a single afternoon dose of effervescent levodopa-carbidopa preparation (CHF 1512) in fluctuating Parkinson disease
Fabrizio Stocchi et al.
CLINICAL NEUROPHARMACOLOGY (2007)
Selegiline orally disintegrating tablets in patients with Parkinson disease and wearing off symptoms
William G. Ondo et al.
CLINICAL NEUROPHARMACOLOGY (2007)
Overnight switch from oral dopaminergic agonists to transdermal rotigotine patch in subjects with Parkinson disease
Peter A. LeWitt et al.
CLINICAL NEUROPHARMACOLOGY (2007)
Fibrotic heart-valve reactions to dopamine-agonist treatment in Parkinson's disease
Angelo Antonini et al.
LANCET NEUROLOGY (2007)
Effect of cabergoline added to levodopa treatment on sleep-wake cycle in idiopathic Parkinson's disease: an open label 24-hour polysomnographic study
A. Romigi et al.
JOURNAL OF NEURAL TRANSMISSION (2006)
Early piribedil monotherapy of Parkinson's disease: A planned seven-month report of the REGAIN study
Olivier Rascol et al.
MOVEMENT DISORDERS (2006)
Unilateral pallidotomy versus bilateral subthalamic nucleus stimulation in Parkinson's disease: one year follow-up of a randomised observer-blind multi centre trial
R. A. J. Esselink et al.
ACTA NEUROCHIRURGICA (2006)
Effects of rivastigmine in patients with and without visual hallucinations in dementia associated with Parkinson's disease
David Burn et al.
MOVEMENT DISORDERS (2006)
Rater-blinded, prospective comparison: Quetiapine versus clozapine for Parkinson's disease psychosis
Doron Merims et al.
CLINICAL NEUROPHARMACOLOGY (2006)
Review of the therapeutic management of Parkinson's disease. Report of a joint task force of the European Federation of Neurological Societies and the Movement Disorder Society- European Section. Part I: Early (uncomplicated) Parkinson's disease
M. Horstink et al.
EUROPEAN JOURNAL OF NEUROLOGY (2006)
Review of the therapeutic management of Parkinson's disease. Report of a joint task force of the European Federation of Neurological Societies (EFNS) and the Movement Disorder Society-European Section (MDS-ES). Part II: late (complicated) Parkinson's disease
M. Horstink et al.
EUROPEAN JOURNAL OF NEUROLOGY (2006)
A randomized trial of deep-brain stimulation for Parkinson's disease
Guenther Deuschl et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Use of pramipexole in REM sleep behavior disorder: Results from a case series
Markus H. Schmidt et al.
SLEEP MEDICINE (2006)
Randomized study of sertraline and low-dose amitriptyline in patients with Parkinson's disease and depression: Effect on quality of life
Angelo Antonini et al.
MOVEMENT DISORDERS (2006)
Neuropsychological effects of bilateral STN stimulation in Parkinson disease - A controlled study
HMM Smeding et al.
NEUROLOGY (2006)
Qigong exercise for the symptoms of Parkinson's disease:: a randomized, controlled pilot study
T Schmitz-Hübsch et al.
MOVEMENT DISORDERS (2006)
Effects of bilateral subthalamic nucleus stimulation on sleep, daytime sleepiness, and early morning dystonia in patients with Parkinson disease
KE Lyons et al.
JOURNAL OF NEUROSURGERY (2006)
The Parkinson-control study: A 1-year randomized, double-blind trial comparing piribedil (150 mg/day) with bromocriptine (25 mg/day) in early combination with levodopa in Parkinson's disease
A Castro-Caldas et al.
MOVEMENT DISORDERS (2006)
Pergolide versus levodopa monotherapy in early Parkinson's disease patients:: The PELMOPET study
WH Oertel et al.
MOVEMENT DISORDERS (2006)
Sleep disruption, daytime somnolence and 'sleep attacks' in Parkinson's disease: a clinical survey in PD patients and age-matched healthy volunteers
JJ Ferreira et al.
EUROPEAN JOURNAL OF NEUROLOGY (2006)
Subthalamic nucleus deep brain stimulation: Summary and meta-analysis of outcomes
Galit Kleiner-Fisman et al.
MOVEMENT DISORDERS (2006)
Deep brain stimulation: Preoperative issues
Anthony E. Lang et al.
MOVEMENT DISORDERS (2006)
Deep brain stimulation: Postoperative issues
Guenther Deuschl et al.
MOVEMENT DISORDERS (2006)
Central acute D2 stimulation worsens bladder function in patients with mild Parkinson's disease
L Brusa et al.
JOURNAL OF UROLOGY (2006)
Stimulation of the subthalamic nucleus in Parkinson's disease:: a 5 year follow up
WMM Schüpbach et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2005)
Modafinil for daytime somnolence in Parkinson's disease: double blind, placebo controlled parallel trial
WG Ondo et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2005)
Bilateral deep brain stimulation in Parkinson's disease: a multicentre study with 4 years follow-up
MC Rodriguez-Oroz et al.
BRAIN (2005)
A systematic review of prevalence studies of dementia in Parkinson's disease
D Aarsland et al.
MOVEMENT DISORDERS (2005)
Melatonin for sleep disturbances in Parkinson's disease
GA Dowling et al.
SLEEP MEDICINE (2005)
Double-blind, placebo-controlled, unforced titration parallel trial of quetiapine for dopaminergic-induced hallucinations in Parkinson's disease
WG Ondo et al.
MOVEMENT DISORDERS (2005)
Sudden uncontrollable somnolence and medication use in Parkinson disease
J Avorn et al.
ARCHIVES OF NEUROLOGY (2005)
Characteristics of idiopathic REM sleep behavior disorder and that associated with MSA and PD
A Iranzo et al.
NEUROLOGY (2005)
Donepezil for dementia in Parkinson's disease: a randomised, double blind, placebo controlled, crossover study
B Ravina et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2005)
Quetiapine for insomnia in Parkinson disease -: Results from an open-label trial
C Juri et al.
CLINICAL NEUROPHARMACOLOGY (2005)
Long-term efficacy and safety of pramipexole in advanced Parkinson's disease:: Results from a European multicenter trial
JC Möller et al.
MOVEMENT DISORDERS (2005)
Nocturnal activity with nighttime pergolide in Parkinson disease: A controlled study using actigraphy
CL Comella et al.
NEUROLOGY (2005)
Motor fluctuations and dyskinesias in Parkinson's disease: clinical manifestations
J Jankovic
MOVEMENT DISORDERS (2005)
Efficacy of a physical therapy program in patients with Parkinson's disease: A randomized controlled trial
T Ellis et al.
ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION (2005)
Nonmotor complications in Parkinson's disease
CH Adler
MOVEMENT DISORDERS (2005)
Rasagiline as an adjunct to levodopa in patients with Parkinson's disease and motor fluctuations (LARGO, Lasting effect in Adjunct therapy with Rasagiline Given Once daily, study): a randomised, double-blind, parallel-group trial
O Rascol et al.
LANCET (2005)
Continuous subcutaneous apomorphine therapy improves Dyskinesias in Parkinson's disease: A prospective study using single-dose challenges
R Katzenschlager et al.
MOVEMENT DISORDERS (2005)
Sydney multicenter study of Parkinson's disease: non-L-dopa-responsive problems dominate at 15 years
MA Hely et al.
MOVEMENT DISORDERS (2005)
Duodenal levodopa infusion monotherapy vs oral polypharmacy in advanced Parkinson disease
D Nyholm et al.
NEUROLOGY (2005)
Increased gastric motility during 5-HT4 agonist therapy reduces response fluctuations in Parkinson's disease
H Asai et al.
PARKINSONISM & RELATED DISORDERS (2005)
Efficacy of combining levodopa with entacapone on quality of life and activities of daily living in patients experiencing wearing-off type fluctuations
H Reichmann et al.
ACTA NEUROLOGICA SCANDINAVICA (2005)
Antidepressant studies in Parkinson's disease: A review and meta-analysis
D Weintraub et al.
MOVEMENT DISORDERS (2005)
Treatment of Parkinson's disease with pergolide and relation to restrictive valvular heart disease
G Van Camp et al.
LANCET (2004)
Zydis selegiline reduces off time in Parkinson's disease patients with motor fluctuations:: A 3-month, randomized, placebo-controlled study
CH Waters et al.
MOVEMENT DISORDERS (2004)
Conversion from dopamine agonists to pramipexole - An open-label trial in 227 patients with advanced Parkinson's disease
G Linazasoro
JOURNAL OF NEUROLOGY (2004)
Effects of bilateral subthalamic stimulation on sleep in Parkinson's disease
C Monaca et al.
JOURNAL OF NEUROLOGY (2004)
Improvement of sleep quality in patients with advanced Parkinson's disease treated with deep brain stimulation of the subthalamic nucleus
N Hjort et al.
MOVEMENT DISORDERS (2004)
Unilateral pallidotomy versus bilateral subthalamic nucleus stimulation in PD - A randomized trial
RAJ Esselink et al.
NEUROLOGY (2004)
Monoamine oxidase type B inhibitors in early Parkinson's disease: meta-analysis of 17 randomised trials involving 3525 patients
NJ Ives et al.
BMJ-BRITISH MEDICAL JOURNAL (2004)
Guidance for the preparation of neurological management guidelines by EFNS scientific task forces - revised recommendations 2004
M Brainin et al.
EUROPEAN JOURNAL OF NEUROLOGY (2004)
Treatments for dysarthria in Parkinson's disease
S Pinto et al.
LANCET NEUROLOGY (2004)
Rivastigmine for dementia associated with Parkinson's disease
M Emre et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Quetiapine and clozapine in parkinsonian patients with dopaminergic psychosis
L Morgante et al.
CLINICAL NEUROPHARMACOLOGY (2004)
Effect of subthalamic deep brain stimulation on the function of the urinary bladder
C Seif et al.
ANNALS OF NEUROLOGY (2004)
Long-term results of bilateral pallidal stimulation in Parkinson's disease
J Volkmann et al.
ANNALS OF NEUROLOGY (2004)
Switching from ergot to nonergot dopamine agonists in Parkinson's disease: A clinical series and five-drug dose conversion table
K Grosset et al.
MOVEMENT DISORDERS (2004)
Long term effects of bilateral subthalamic nucleus stimulation on cognitive function, mood, and behaviour in Parkinson's disease
A Funkiewiez et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2004)
The long-acting dopamine receptor agonist cabergoline in early Parkinson's disease - Final results of a 5-year, double-blind, Levodopa-controlled study
F Bracco et al.
CNS DRUGS (2004)
Randomized placebo-controlled trial of donepezil in cognitive impairment in Parkinson's disease
I Leroi et al.
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2004)
Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease
P Krack et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Randomized, double-blind study of pramipexole with placebo and bromocriptine in advanced Parkinson's disease
Y Mizuno et al.
MOVEMENT DISORDERS (2003)
Does nefazodone improve both depression and Parkinson disease? A pilot randomized trial
A Avila et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2003)
The effect of cabergoline on sleep, periodic leg movements in sleep, and early morning motor function in patients with Parkinson's disease
B Högl et al.
NEUROPSYCHOPHARMACOLOGY (2003)
A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease
CW Olanow et al.
ANNALS OF NEUROLOGY (2003)
Long-term follow up of bilateral deep brain stimulation of the subthalamic nucleus in patients with advanced Parkinson disease
G Kleiner-Fisman et al.
JOURNAL OF NEUROSURGERY (2003)
Entacapone is beneficial in both fluctuating and non-fluctuating patients with Parkinson's disease: a randomised, placebo controlled, double blind, six month study
DJ Brooks et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2003)
Effects of pallidotomy and bilateral subthalamic stimulation on cognitive function in Parkinson disease -: A controlled comparative study
A Gironell et al.
JOURNAL OF NEUROLOGY (2003)
Slower progression of Parkinson's disease with ropinirole versus levodopa: The REAL-PET study
AL Whone et al.
ANNALS OF NEUROLOGY (2003)
Pramipexole and pergolide in the treatment of depression in Parkinson's disease:: a national multicentre prospective randomized study
I Rektorová et al.
EUROPEAN JOURNAL OF NEUROLOGY (2003)
Sleep attacks, daytime sleepiness, and dopamine agonists in Parkinson's disease
S Paus et al.
MOVEMENT DISORDERS (2003)
Randomized trial of pallidotomy versus medical therapy for Parkinson's disease
JL Vitek et al.
ANNALS OF NEUROLOGY (2003)
Short-term effect of a single levodopa dose on micturition disturbance in Parkinson's disease patients with the wearing-off phenomenon
T Uchiyama et al.
MOVEMENT DISORDERS (2003)
High-dose ropinirole in advanced Parkinson's disease with severe dyskinesias
S Cristina et al.
CLINICAL NEUROPHARMACOLOGY (2003)
Efficacy of piribedil as early combination to levodopa in patients with stable Parkinson's disease: A 6-month, randomized, placebo-controlled study
M Ziegler et al.
MOVEMENT DISORDERS (2003)
0.2-Hz repetitive transcranial magnetic stimulation has no add-on effects as compared to a realistic sham stimulation in Parkinson's disease
S Okabe et al.
MOVEMENT DISORDERS (2003)
Effects of subthalamic nucleus stimulation on urodynamic findings in patients with Parkinson's disease
E Finazzi-Agrò et al.
JOURNAL OF UROLOGY (2003)
Increased daytime sleepiness in Parkinson's disease:: A questionnaire survey
B Högl et al.
MOVEMENT DISORDERS (2003)
Prevalence and characteristics of dementia in Parkinson disease - An 8-year prospective study
D Aarsland et al.
ARCHIVES OF NEUROLOGY (2003)
Randomized trial of modafinil for treating subjective daytime sleepiness in patients with Parkinson's disease
CH Adler et al.
MOVEMENT DISORDERS (2003)
Improvement of voicing in patients with Parkinson's disease by speech therapy
BJM de Swart et al.
NEUROLOGY (2003)
Cognitive and behavioural effects of chronic stimulation of the subthalamic nucleus in patients with Parkinson's disease
A Daniele et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2003)
Randomized, double-blind trial of glial cell line-derived neurotrophic factor (GDNF) in PD
JG Nutt et al.
NEUROLOGY (2003)
Switching and combining dopamine agonists
H Reichmann et al.
JOURNAL OF NEURAL TRANSMISSION (2003)
Effect on mood of subthalamic DBS for Parkinson's disease - A consecutive series of 24 patients
A Berney et al.
NEUROLOGY (2002)
Apomorphine monotherapy in the treatment of refractory motor complications of Parkinson's disease: Long-term follow-up study of 64 patients
AJ Manson et al.
MOVEMENT DISORDERS (2002)
Effects of coenzyme Q10 in early Parkinson disease -: Evidence of slowing of the functional decline
CW Shults et al.
ARCHIVES OF NEUROLOGY (2002)
Olanzapine in the treatment of dopamimetic-induced psychosis in patients with Parkinson's disease
A Breier et al.
BIOLOGICAL PSYCHIATRY (2002)
Olanzapine treatment for dopaminergic-induced hallucinations
WG Ondo et al.
MOVEMENT DISORDERS (2002)
Systematic review of paramedical therapies for Parkinson's disease
KHO Deane et al.
MOVEMENT DISORDERS (2002)
Pramipexole in patients with Parkinson's disease and marked drug resistant tremor: a randomised, double blind, placebo controlled multicentre study
O Pogarell et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2002)
Behavioural disorders, Parkinson's disease and subthalamic stimulation
JL Houeto et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2002)
Donepezil for cognitive impairment in Parkinson's disease: a randomised controlled study
D Aarsland et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2002)
Beyond the iron mask: Towards better recognition and treatment of depression associated with Parkinson's disease
DJ Burn
MOVEMENT DISORDERS (2002)
Impact of sustained deprenyl (selegiline) in levodopa-treated Parkinson's disease: A randomized placebo-controlled extension of the deprenyl and tocopherol antioxidative therapy of parkinsonism trial
I Shoulson et al.
ANNALS OF NEUROLOGY (2002)
Apomorphine as an alternative to sildenafil in Parkinson's disease
JD O'Sullivan
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2002)
Sleep symptoms and polysomnographic architecture in advanced Parkinson's disease after chronic bilateral subthalamic stimulation
A Iranzo et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2002)
Morbidity and mortality following pallidotomy in Parkinson's disease - A systematic review
RMA de Bie et al.
NEUROLOGY (2002)
Donepezil in the treatment of hallucinations and delusions in Parkinson's disease
G Fabbrini et al.
NEUROLOGICAL SCIENCES (2002)
Excessive daytime sleepiness and sudden-onset sleep in Parkinson disease - A survey by the Canadian Movement Disorders Group
DE Hobson et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
Stereotactic neurosurgery for tremor
JD Speelman et al.
MOVEMENT DISORDERS (2002)
Levodopa-induced dyskinesias and continuous subcutaneous infusions of apomorphine: Results of a two-year, prospective follow-up
P Kanovsky et al.
MOVEMENT DISORDERS (2002)
A double-blind, placebo-controlled and longitudinal study of riluzole in early Parkinson's disease
J Jankovic et al.
PARKINSONISM & RELATED DISORDERS (2002)
Successful use of donepezil for the treatment of psychotic symptoms in patients with Parkinson's disease
J Bergman et al.
CLINICAL NEUROPHARMACOLOGY (2002)
Rivastigmine for the treatment of dementia and visual hallucinations associated with Parkinson's disease: A case series
R Bullock et al.
CURRENT MEDICAL RESEARCH AND OPINION (2002)
A six-month multicentre, double-blind, bromocriptine-controlled study of the safety and efficacy of ropinirole in the treatment of patients with Parkinson's disease not optimally controlled by L-dopa
ER Brunt et al.
JOURNAL OF NEURAL TRANSMISSION (2002)
Rivastigmine in the treatment of parkinsonian psychosis anti cognitive impairment: Preliminary findings from an open trial
PJ Reading et al.
MOVEMENT DISORDERS (2001)
Levodopa prolongs life expectancy and is non-toxic to substantia nigra
AH Rajput
PARKINSONISM & RELATED DISORDERS (2001)
Intensive voice treatment (LSVT®) for patients with Parkinson's disease:: a 2 year follow up
LO Ramig et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2001)
Deep-brain stimulation of the subthalamic nucleus or the pars interna of the globus pallidus in Parkinson's disease.
JA Obeso et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Randomized trial of tolcapone versus pergolide as add-on to levodopa therapy in Parkinson's disease patients with motor fluctuations
W Koller et al.
MOVEMENT DISORDERS (2001)
Treatment of erectile dysfunction with sildenafil citrate (Viagra) in parkinsonism due to Parkinson's disease or multiple system atrophy with observations
IF Hussain et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2001)
A randomized, double-blind, placebo-controlled trial of subcutaneously injected apomorphine for Parkinsonian off-state events
RB Dewey et al.
ARCHIVES OF NEUROLOGY (2001)
Effects of bilateral subthalamic stimulation on cognitive function in Parkinson disease
M Alegret et al.
ARCHIVES OF NEUROLOGY (2001)
Influence of chronic bilateral stimulation of the subthalamic nucleus on cognitive function in Parkinson's disease
K Dujardin et al.
JOURNAL OF NEUROLOGY (2001)
An algorithm (decision tree) for the management of Parkinson's disease (2001): Treatment guidelines
CW Olanow et al.
NEUROLOGY (2001)
Intravenous amantadine improves levadopa-induced dyskinesias: An acute double-blind placebo-controlled study
P Del Dotto et al.
MOVEMENT DISORDERS (2001)
Transplantation of embryonic dopamine neurons for severe Parkinson's disease.
CR Freed et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Subcutaneous continuous apomorphine infusion in fluctuating patients with Parkinson's disease: long-term results
F Stocchi et al.
NEUROLOGICAL SCIENCES (2001)
Twelve-month safety of entacapone in patients with Parkinson's disease
VV Myllyla et al.
EUROPEAN JOURNAL OF NEUROLOGY (2001)
Switching from pergolide to pramipexole in patients with Parkinson's disease
PA Hanna et al.
JOURNAL OF NEURAL TRANSMISSION (2001)
Increased risk of somnolence with the new dopamine agonists in patients with Parkinson's disease - A meta-analysis of randomised controlled trials
M Etminan et al.
DRUG SAFETY (2001)
Improvement of sleep architecture in PD with subthalamic nucleus stimulation
I Arnulf et al.
NEUROLOGY (2000)
Pramipexole vs levodopa as initial treatment for Parkinson disease - A randomized controlled trial
R Holloway et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2000)
Neuropsychological consequences of chronic bilateral stimulation of the subthalamic nucleus in Parkinson's disease
JA Saint-Cyr et al.
BRAIN (2000)
Alpha-dihydroergocryptine in the treatment of de novo parkinsonian patients:: results of a multicentre, randomized, double-blind, placebo-controlled study
B Bergamasco et al.
ACTA NEUROLOGICA SCANDINAVICA (2000)
A five-year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole or levodopa
O Rascol et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Neuropsychological outcome of GPi pallidotomy and GPi or STN deep brain stimulation in Parkinson's disease
LL Trépanier et al.
BRAIN AND COGNITION (2000)
Transplantation of embryonic porcine mesencephalic tissue in patients with PD
JM Schumacher et al.
NEUROLOGY (2000)
Hallucinations in Parkinson's disease -: Prevalence, phenomenology and risk factors
G Fénelon et al.
BRAIN (2000)
Rapid eye movement sleep behaviour disorder: demographic, clinical and laboratory findings in 93 cases
EJ Olson et al.
BRAIN (2000)
Amantadine infusion in treatment of motor fluctuations and dyskinesias in Parkinson's disease
E Ruzicka et al.
JOURNAL OF NEURAL TRANSMISSION (2000)
What contributes to quality of life in patients with Parkinson's disease?
A Schrag et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2000)
The effect of amantadine on levodopa-induced dyskinesias in Parkinson's disease: A double-blind, placebo-controlled study
BJ Snow et al.
CLINICAL NEUROPHARMACOLOGY (2000)
Five-year follow-up of early lisuride and levodopa combination therapy versus levodopa monotherapy in de novo Parkinson's disease
H Allain et al.
EUROPEAN NEUROLOGY (2000)
Share Paper
